Cpex Pharmaceuticals Overview
- Founded
-
2007

- Status
-
Acquired/Merged
- Employees
-
13

- Latest Deal Type
-
M&A
- Financing Rounds
-
3
Cpex Pharmaceuticals General Information
Description
Developer of drug delivery technologies. The company is engaged in the development, licensing and commercialization of pharmaceutical products utilizing its drug delivery platform technology.
Contact Information
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Pharmaceuticals
Parent Company
Xstelos Holdings
Primary Office
- 2 Holland Way
- Exeter, NH 03833
- United States
+1 (603) 000-0000
Cpex Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Cpex Pharmaceuticals Patents
Cpex Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-2694076-A1 | Nasal formulations of benzodiazepine | Withdrawn | 01-Apr-2011 | 00000000000 | |
EP-2694076-A4 | Nasal formulations of benzodiazepine | Withdrawn | 01-Apr-2011 | 00000000000 | |
US-20160199296-A1 | Nasal formulations of benzodiazepine | Abandoned | 01-Apr-2011 | 0000000000 | |
US-20140128379-A1 | Nasal formulations of benzodiazepine | Abandoned | 01-Apr-2011 | 00000000000 | |
US-20110097363-A1 | Therapeutically effective preparations of insulin | Abandoned | 22-Oct-2009 | A61K9/0043 | 0 |
Cpex Pharmaceuticals Signals
Cpex Pharmaceuticals Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|